Have you taken an at-home genetic test from a direct to consumer (DTC) provider such as 23andMe, Ancestry, FamilyTreeDNA, or MyHeritage and wondered what other information is available? MyGenomeRx offers pharmacogenomic reports that are:
Rapid: Reports are delivered back in seconds
In-Depth: Analysis of over 1 million rsIDs, from 2038 different genes
Personal: Reports based on an individuals’ DNA and medication profile
Detailed: Provides genotype and star allele information used to determine metabolic phenotypes for dose adjustment/optimization
Relevant: We analyze raw DNA data for issues related to how individuals respond to medications
Safe: Our data security is compliant with the Health Insurance Portability and Accountability Act (HIPAA) requirements regarding protected health information
Readily Available: MyGenomeRx uses information from a raw DNA file that anyone has undergone DTC genetic testing already has in hand, with no need for additional testing
Private: YOU control the results and can choose who to share them with
Educational: Our service is not to be used as medical advice or as a diagnostic tool, but it does provide important insights based on a consumers’ DNA that allow for a more personalized approach to medication management when working with healthcare providers
MyGenomeRx Offers Two Reports
Drug-Drug Interaction Report
$19.99 Free
- If you take more than one medication you are at risk of a drug interaction
- The more medications you take, the higher the risk for drug-drug interactions
- Drug-drug interactions can alter the action of either or both drugs
- Based on provided list of medications
Pharmacogenomics Report
$59.99
- Based on provided list of medications
- Identifies when your DNA may affect medication responses
- Useful even if not taking medications as highlights any star alleles identified
- All DNA screened for a set of 15 medications including common drugs such as acetaminophen, aspirin, ibuprofen, and naproxen
- Includes Drug-Drug Interaction Report
Learn how your DNA results can help guide your drug therapy
Pharmacogenomics combines pharmacology (the study of drugs) and genomics (the study of genes and their functions) and involves how variations in a person’s DNA can affect their response to drugs. From the moment you take a drug, your body begins to process it, in an effort to eliminate it.
Most medications are metabolized to facilitate their removal. These chemical transformations can increase or decrease a drug’s pharmacological activity. When metabolism converts the drug to a more active form the drug is called a “pro-drug” and the more active form is called the “active metabolite”. Modifications can also alter how long the drug stays in your body (half-life).
There can be considerable variation in how people metabolize drugs. DNA is an important factor in determining the speed at which drugs are metabolized. If someone has a genetic polymorphism in an enzyme responsible for the metabolism of a drug, it can influence their drug exposure, clinical response, and risk for adverse effects.
MyGenomeRx is dedicated to delivering information on how an individual’s DNA may alter the way they respond to certain medications to provide a more personalized approach to their drug treatment plan.
MyGenomeRx reports should be used with guidance from your healthcare provider.